SA
SHSSX logo
BlackRock Health Sciences Opportunities Portfolio Institutional Shares(SHSSX)
Last print 14 weeks agoAbout this dataData status
$73.53▼-1.38 (-1.84%)Stale · 14 weeks old

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 29.8 · elevated volatility

Overview →

BlackRock Health Sciences Opportunities Portfolio Institutional Shares (SHSSX) focuses on investments in the health sciences sector, leveraging BlackRock's extensive research capabilities and global reach. The portfolio is positioned to capitalize on trends in biotechnology, pharmaceuticals, and healthcare services, aiming to deliver superior returns through a diversified approach.

Financial ServicesAsset Managementmoderate - the fund's operating leverage is moderate due to the variable nature of management fees linked to performance.

Business Overview

01Management fees from health sciences investments (exact % not disclosed)
02Performance fees based on fund performance (exact % not disclosed)

The fund generates revenue primarily through management and performance fees, which are contingent on the fund's performance relative to benchmarks. BlackRock's competitive advantage lies in its extensive data analytics capabilities and established relationships with healthcare companies, allowing for informed investment decisions.

What Moves the Stock

Changes in healthcare regulations impacting investment opportunities

Performance of key holdings in biotechnology and pharmaceuticals

Market sentiment towards health sciences as a growth sector

Overall economic conditions affecting healthcare spending

Watch on Earnings
Total assets under management (AUM)Performance relative to benchmark indicesNet inflows/outflows from the fund

Risk Factors

Regulatory changes affecting drug approval processes

Technological disruption in healthcare delivery models

Intensifying competition from other healthcare-focused funds

Emerging investment vehicles such as ETFs that target health sciences

Liquidity risk associated with large-scale redemptions

Market risk from volatility in healthcare stocks

StructuralCompetitiveBalance Sheet

Macro Sensitivity

Economic Cycle

moderate - the health sciences sector is somewhat insulated from economic downturns, but overall spending on healthcare can be affected by GDP growth.

Interest Rates

Higher interest rates can impact the valuations of healthcare companies, leading to potential declines in fund performance as borrowing costs rise for biotech firms.

Credit

minimal - the fund does not have significant credit exposure as it primarily invests in equities.

Live Conditions
30-Year TreasuryS&P 500 Futures10-Year TreasuryRussell 2000 Futures5-Year Treasury2-Year TreasuryDow Jones Futures30-Day Fed Funds

Profile

growth - the fund appeals to investors seeking exposure to high-growth sectors within healthcare.

moderate - the fund's historical volatility aligns with the broader healthcare sector, which can experience fluctuations.

Key Metrics to Watch
Total assets under management (AUM)
Performance relative to the S&P 500 Healthcare Index
Healthcare sector ETF performance
Net inflows/outflows from the fund
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.